Georgia's Online Cancer Information Center

Panel: Don't Get PSA Prostate Cancer Screen

5/24/2012

Harm Outweighs Benefit of Routine Prostate Cancer Screening, Task Force Says May 21, 2012 -- Men should not get routine PSA tests to screen for prostate cancer, the U.S. Preventive Services Task Force today reaffirmed. The USPSTF is the independent panel that sets U.S. cancer-screening policy. Last October, the group released a draft report finding that men get far more harm than benefit from routine PSA tests. That set off howls of protests from many urologists and some patient groups that strongly support routine PSA screening. Would the USPSTF back down? No. Today's final decision fully adopts the draft report. "The task force has not changed its final conclusion," task force co-chair Michael LeFevre, MD, MSPH, tells WebMD. "Many men will be harmed by prostate cancer screening. Very few will benefit. The benefits do not outweigh the harms, and therefore we do not recommend screening." View Full Article View US Preventative Services Task Force's Current Recommendation

Media, News & Events

Lawmakers conclude listening tour on access to cancer care

Rep. Lee Hawkins, R-Gainesville, the committee’s chairman, said he and other lawmakers are working on drug pricing and other issues. He wrapped up the committee’s listening tour by saying the General Assembly will continue to study cancer care access.

7/14/2025

PCOM S. Georgia student receives third cancer research award

Med student from south Georgia wins awards to advance cancer research.

5/08/2025

GCRCCP honored by ACS National Colorectal Cancer Roundtable

The Georgia Colorectal Cancer Control Program won the 2025 American Cancer Society's NCCRT National Achievement Award.

3/04/2025

Georgia CORE introduces a resource guide for barriers to cancer clinical trials

We invite you to download and share it, and let us know if there is anything we should add to it.

1/14/2025

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now